Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

RNA-targeting CRISPR systems from metagenomic discovery to transcriptomic engineering.

Smargon AA, Shi YJ, Yeo GW.

Nat Cell Biol. 2020 Feb;22(2):143-150. doi: 10.1038/s41556-019-0454-7. Epub 2020 Feb 3. Review.

PMID:
32015437
2.

Diversity and evolution of class 2 CRISPR-Cas systems.

Shmakov S, Smargon A, Scott D, Cox D, Pyzocha N, Yan W, Abudayyeh OO, Gootenberg JS, Makarova KS, Wolf YI, Severinov K, Zhang F, Koonin EV.

Nat Rev Microbiol. 2017 Mar;15(3):169-182. doi: 10.1038/nrmicro.2016.184. Epub 2017 Jan 23.

3.

Cas13b Is a Type VI-B CRISPR-Associated RNA-Guided RNase Differentially Regulated by Accessory Proteins Csx27 and Csx28.

Smargon AA, Cox DBT, Pyzocha NK, Zheng K, Slaymaker IM, Gootenberg JS, Abudayyeh OA, Essletzbichler P, Shmakov S, Makarova KS, Koonin EV, Zhang F.

Mol Cell. 2017 Feb 16;65(4):618-630.e7. doi: 10.1016/j.molcel.2016.12.023. Epub 2017 Jan 5.

4.

Human chitotriosidase polymorphisms G354R and A442V associated with reduced enzyme activity.

Lee P, Waalen J, Crain K, Smargon A, Beutler E.

Blood Cells Mol Dis. 2007 Nov-Dec;39(3):353-60. Epub 2007 Aug 10.

Supplemental Content

Loading ...
Support Center